Clinical Trial Update: Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical tranexamic acid to reduce postoperative blood loss in femoral neck fracture patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Neck Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Dr. Jeff Yach | Conditions: Femoral Neck Fracture | Phase 3 | Status: TERMINATED